A recent study demonstrated that lignans with anti-fibrotic effects also act on CB2 receptors, inhibiting the NF-κB and p38MAPK pathways in Kupffer cells, thus improving CCl4-induced liver fibrosis [98]. This evidence concerns the gene NFKB1 and Hepatic fibrosis.